Translocator protein: Pharmacology and steroidogenesis

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 572-578

  Midzak, Andrew ^a,b   Zirkin, Barry ^c   Papadopoulos, Vassilios ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

14 3 3 proteins; Adrenal; Aging; Brain; Cholesterol; Gonads; Hypercortisolism; Hypogonadism; Mitochondria; Steroidogenesis; Translocator protein (TSPO); Voltage dependent anion channel (VDAC)

Indexed keywords

ACETAMIDE; ACETAMIDE DERIVATIVE; AMIDE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; IMIDAZOPYRIDINE DERIVATIVE; ISOQUINOLINE; MITOCHONDRIAL PROTEIN; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; CHOLESTEROL; ISOQUINOLINE DERIVATIVE; LIGAND; STEROID; TSPO PROTEIN, HUMAN;

ARTICLE; DRUG BINDING SITE; GENETIC MANIPULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; STEROIDOGENESIS; ANIMAL; BINDING SITE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; MOLECULAR MODEL;

ANIMALS; BENZODIAZEPINES; BINDING SITES; CHOLESTEROL; HUMANS; ISOQUINOLINES; LIGANDS; MODELS, MOLECULAR; RECEPTORS, GABA; STEROIDS;

EID: 84938774786     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150061     Document Type: Article

References (75)

1. Saari, T., Uusi-Oukari, M., Ahonen, J. and Olkkola, K.T. (2011) Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol. Rev. 63, 243-267 CrossRef PubMed
2. Anholt, R., Pedersen, P.L., De Souza, E.B. and Snyder, S.H. (1986) The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576-583
3. Anholt, R., De Souza, E.B., Kuhar, M.J. and Snyder, S.H. (1985) Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur. J. Pharmacol. 110, 41-46 CrossRef PubMed
4. Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G. and Weizman, A. (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51, 629-650 PubMed
5. Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacapère, J.J., Lindemann, P., Norenberg, M.D., Nutt, D., Weizman, A., Zhang, M.R. and Gavish, M. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409 CrossRef PubMed
6. Morohaku, K., Pelton, S.H., Daugherty, D.J., Butler, W.R., Deng, W. and Selvaraj, V. (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155, 89-97 CrossRef PubMed
7. Tu, L., Morohaku, K., Manna, P.R., Pelton, S.H., Butler, W.R., Stocco, D.M. and Selvaraj, V. (2014) Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 289, 27444-27454 CrossRef PubMed
8. Banati, R., Middleton, R.J., Chan, R., Hatty, C.R., Kam, W.W., Quin, C., Graeber, M.B., Parmar, A., Zahra, D., Callaghan, P. et al. (2014) Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452 CrossRef PubMed
9. Selvaraj, V., Stocco, D. and Tu, L. (2015) Translocator protein (TSPO) and steroidogenesis: a reappraisal. Mol. Endocrinol. 29, 490-501 CrossRef PubMed
10. Miller, W. and Auchus, R. (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81-151 CrossRef PubMed
11. Payne, A. and Hales, D. (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25, 947-970 CrossRef PubMed
12. Privalle, C., McNamara, B.C., Dhariwal, M.S. and Jefcoate, C.R. (1987) ACTH control of cholesterol side-chain cleavage at adrenal mitochondrial cytochrome P-450scc. Regulation of intramitochondrial cholesterol transfer. Mol. Cell. Endocrinol. 53, 87-101 CrossRef PubMed
13. Tuckey, R. (2005) Progesterone synthesis by the human placenta. Placenta 26, 273-281 CrossRef PubMed
14. Schumacher, M., Akwa, Y., Guennoun, R., Robert, F., Labombarda, F., Desarnaud, F., Robel, P., De Nicola, A.F. and Baulieu, E.E. (2000) Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29, 307-326 CrossRef PubMed
15. Scarf, A., Ittner, L. and Kassiou, M. (2009) The translocator protein (18 kDa): central nervous system disease and drug design. J. Med. Chem. 52, 581-592 CrossRef PubMed
16. Owen, D. and Matthews, P. (2011) Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands. Int. Rev. Neurobiol. 101, 19-39 CrossRef PubMed
17. Veenman, L. and Gavish, M. (2012) The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr. Mol. Med. 12, 398-412 PubMed
18. Marc, V. and Morselli, P. (1969) Effect of diazepam on plasma corticosterone levels in the rat. J. Pharm. Pharmacol. 21, 784-786 CrossRef PubMed
19. Costa, E. and Guidotti, A. (1991) Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci. 49, 325-344 CrossRef PubMed
20. Fan, J., Liu, J., Culty, M. and Papadopoulos, V. (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog. Lipid Res. 49, 218-234 CrossRef PubMed
21. Guidotti, A., Forchetti, C.M., Corda, M.G., Konkel, D., Bennett, C.D. and Costa, E. (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. U.S.A. 80, 3531-3535 CrossRef PubMed
22. Yanagibashi, K., Ohno, Y., Kawamura, M. and Hall, P.F. (1988) The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. Endocrinology 123, 2075-2082 CrossRef PubMed
23. Besman, M., Yanagibashi, K., Lee, T.D., Kawamura, M., Hall, P.F. and Shively, J.E. (1989) Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 86, 4897-4901 CrossRef PubMed
24. Bovolin, P., Schlichting, J., Miyata, M., Ferrarese, C., Guidotti, A. and Alho, H. (1990) Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul. Pept. 29, 267-281 CrossRef PubMed
25. Schultz, R., Pelto-Huikko, M. and Alho, H. (1992) Expression of diazepam binding inhibitor-like immunoreactivity in rat testis is dependent on pituitary hormones. Endocrinology 130, 3200-3206 PubMed
26. Cavallaro, S., Pani, L., Guidotti, A. and Costa, E. (1993) ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action. Life Sci. 53, 1137-1147 CrossRef PubMed
27. Boujrad, N., Hudson, J.J.R. and Papadopoulos, V. (1993) Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90, 5728-5731 CrossRef PubMed
28. Ohgami, R., Campagna, D.R., Antiochos, B., Wood, E.B., Sharp, J.J., Barker, J.E. and Fleming, M.D. (2005) nm1054: A spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood 106, 3625-3631 CrossRef PubMed
29. Landrock, D., Atshaves, B.P., McIntosh, A.L., Landrock, K.K., Schroeder, F. and Kier, A.B. (2010) Acyl-CoA binding protein gene ablation induces pre-implantation embryonic lethality in mice. Lipids 45, 567-580 CrossRef PubMed
30. Neess, D., Bloksgaard, M., Bek, S., Marcher, A.B., Elle, I.C., Helledie, T., Due, M., Pagmantidis, V., Finsen, B., Wilbertz, J. et al. (2011) Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning. J. Biol. Chem. 286, 3460-3472 CrossRef PubMed
31. Neess, D., Bek, S., Bloksgaard, M., Marcher, A.B., Færgeman, N.J. and Mandrup, S. (2013) Delayed hepatic adaptation to weaning in ACBP-/-mice is caused by disruption of the epidermal barrier. Cell Rep. 5, 1403-1412 CrossRef PubMed
32. Lee, L., DeBono, C.A., Campagna, D.R., Young, D.C., Moody, D.B. and Fleming, M.D. (2007) Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skin. J. Invest. Dermatol. 127, 16-23 CrossRef PubMed
33. Christian, C., Herbert, A.G., Holt, R.L., Peng, K., Sherwood, K.D., Pangratz-Fuehrer, S., Rudolph, U. and Huguenard, J.R. (2013) Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor. Neuron 78, 1063-1074 CrossRef PubMed
34. Papadopoulos, V., Mukhin, A.G., Costa, E. and Krueger, K.E. (1990) The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265, 3772-3779 PubMed
35. Mukhin, A., Papadopoulos, V., Costa, E. and Krueger, K.E. (1989) Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 86, 9813-9816 CrossRef PubMed
36. Romeo, E., Auta, J., Kozikowski, A.P., Ma, D., Papadopoulos, V., Puia, G., Costa, E. and Guidotti, A. (1992) 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262, 971-978 PubMed
37. Papadopoulos, V., Nowzari, F. and Krueger, K. (1991) Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. Tropic hormone action on steroid biosynthesis is inhibited by flunitrazepam. J. Biol. Chem. 266, 3682-3687 PubMed
38. Blahos, J., Whalin, M. and Krueger, K. (1995) Identification and purification of a 10-kilodalton protein associated with mitochondrial benzodiazepine receptors. J. Biol. Chem. 270, 20285-20291 CrossRef PubMed
39. Papadopoulos, V., Guarneri, P., Kreuger, K.E., Guidotti, A. and Costa, E. (1992) Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 5113-5117 CrossRef PubMed
40. Costa, B., Pozzo, E.D. and Martini, C. (2012) Translocator protein as a promising target for novel anxiolytics. Curr. Top Med. Chem. 12, 270-285 CrossRef PubMed
41. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D. and Schumacher, M. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug. Discov. 9, 971-988 CrossRef PubMed
42. Rupprecht, R., Rammes, G., Eser, D., Baghai, T.C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H.O., Chaperon, F. et al. (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490-493 CrossRef PubMed
43. Skolnick, P. (2012) Anxioselective anxiolytics: on a quest for the holy grail. Trends Pharmacol. Sci. 33, 611-620 CrossRef PubMed
44. Verleye, M., Akwa, Y., Liere, P., Ladurelle, N., Pianos, A., Eychenne, B., Schumacher, M. and Gillardin, J.M. (2005) The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 82, 712-720 CrossRef PubMed
45. Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M. and Groyer, G. (2012) Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J. Neuroendocrinol. 24, 71-81 CrossRef PubMed
46. Stein, D. (2015) Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial. Adv. Ther. 32, 57-68 CrossRef PubMed
47. Parola, A. and Laird, II, H.E. (1991) The bovine peripheral-type benzodiazepine receptor: a receptor with low affinity for benzodiazepines. Life Sci. 48, 757-64 CrossRef PubMed
48. Owen, D., Yeo, A.J., Gunn, R.N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D.J., Bennacef, I., Parker, C.A. et al. (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 32, 1-5 CrossRef PubMed
49. Wolf, L., Bauer, A., Melchner, D., Hallof-Buestrich, H., Stoertebecker, P., Haen, E., Kreutz, M., Sarubin, N., Milenkovic, V.M., Wetzel, C.H. et al. (2015) Enhancing neurosteroid synthesis - relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines. Pharmacopsychiatry 48, 72-77 CrossRef PubMed
50. Tu, L., Zhao, A.H., Stocco, D.M. and Selvaraj, V. (2015) PK11195 Effect on steroidogenesis is not mediated through the translocator protein (TSPO). Endocrinology 156, 1033-1039 CrossRef PubMed
51. Kenakin, T. (2008) Receptor theory. Curr. Protoc. Pharmacol. Chapter 1, Unit1.2,
52. Lacapère, J., Delavoie, F., Li, H., Péranzi, G., Maccario, J., Papadopoulos, V. and Vidic, B. (2001) Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem. Biophys. Res. Commun. 284, 536-541 CrossRef PubMed
53. Li, H. and Papadopoulos, V. (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997 PubMed
54. Jamin, N., Neumann, J.M., Ostuni, M.A., Vu, T.K., Yao, Z.X., Murail, S., Robert, J.C., Giatzakis, C., Papadopoulos, V. and Lacapère, J.J. (2005) Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19, 588-594 CrossRef PubMed
55. Midzak, A., Midzak, A., Akula, N., Lecanu, L. and Papadopoulos, V. (2011) Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J. Biol. Chem. 286, 9875-9887 CrossRef PubMed
56. Delavoie, F., Li, H., Hardwick, M., Robert, J.C., Giatzakis, C., Péranzi, G., Yao, Z.X., Maccario, J., Lacapère, J.J. and Papadopoulos, V. (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42, 4506-4519 CrossRef PubMed
57. Jaremko, L., Jaremko, M., Giller, K., Becker, S. and Zweckstetter, M. (2014) Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 343, 1363-1366 CrossRef PubMed
58. Guo, Y., Kalathur, R.C., Liu, Q., Kloss, B., Bruni, R., Ginter, C., Kloppmann, E., Rost, B. and Hendrickson, W.A. (2015) Protein structure. Structure and activity of tryptophan-rich TSPO proteins. Science 347, 551-555
59. Li, F., Liu, J., Zheng, Y., Garavito, R.M. and Ferguson-Miller, S. (2015) Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism. Science 347, 555-558 CrossRef PubMed
60. Li, F., Liu, J., Valls, L., Hiser, C. and Ferguson-Miller, S. (2015) Identification of a key cholesterol binding enhancement motif in translocator protein 18 kDa. Biochemistry 54, 1441-1443 CrossRef PubMed
61. Costa, B., Pini, S., Gabelloni, P., Da Pozzo, E., Abelli, M., Lari, L., Preve, M., Lucacchini, A., Cassano, G.B. and Martini, C. (2009) The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology 150, 5438-5445 CrossRef PubMed
62. McEnery, M., Snowman, A.M., Trifiletti, R.R. and Snyder, S.H. (1992) Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A. 89, 3170-3174 CrossRef PubMed
63. Garnier, M., Dimchev, A.B., Boujrad, N., Price, J.M., Musto, N.A. and Papadopoulos, V. (1994) In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol. Pharmacol. 45, 201-211 PubMed
64. Li, H., Degenhardt, B., Tobin, D., Yao, Z.X., Tasken, K. and Papadopoulos, V. (2001) Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. Mol. Endocrinol. 15, 2211-2228PubMed
65. Galiègue, S., Jbilo, O., Combes, T., Bribes, E., Carayon, P., Le Fur, G. and Casellas, P. (1999) Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J. Biol. Chem. 274, 2938-2952 CrossRef PubMed
66. Aghazadeh, Y., Rone, M.B., Blonder, J., Ye, X., Veenstra, T.D., Hales, D.B., Culty, M. and Papadopoulos, V. (2012) Hormone-induced 14-3-3γ adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells. J. Biol. Chem. 287, 15380-15394 CrossRef PubMed
67. Aghazadeh, Y., Martinez-Arguelles, D.B., Fan, J., Culty, M. and Papadopoulos, V. (2014) Induction of androgen formation in the male by a TAT-VDAC1 fusion peptide blocking 14-3-3ε protein adaptor and mitochondrial VDAC1 interactions. Mol. Ther. 22, 1779-1791 CrossRef PubMed
68. Cavallaro, S., Korneyev, A., Guidotti, A. and Costa, E. (1992) Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland. Proc. Natl. Acad. Sci. U.S.A. 89, 10598-10602 CrossRef PubMed
69. Papadopoulos, V., Amri, H., Li, H., Boujrad, N., Vidic, B. and Garnier, M. (1997) Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 272, 32129-32135 CrossRef PubMed
70. Kelly-Hershkovitz, E., Weizman, R., Spanier, I., Leschiner, S., Lahav, M., Weisinger, G. and Gavish, M. (1998) Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J. Biol. Chem. 273, 5478-5483 CrossRef PubMed
71. Hauet, T., Yao, Z.X., Bose, H.S., Wall, C.T., Han, Z., Li, W., Hales, D.B., Miller, W.L., Culty, M. and Papadopoulos, V. (2005) Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol. Endocrinol. 19, 540-554 CrossRef PubMed
72. Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., Li, H., Vidic, B., Brown, A.S. et al. (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62, 21-28 CrossRef PubMed
73. Barbaric, I., Miller, G. and Dear, T. (2007) Appearances can be deceiving: phenotypes of knockout mice. Brief Funct. Genomic Proteomic 6, 91-103 CrossRef PubMed
74. Campioli, E., Fan, J., Midzak, A.S., Culty, M.G. and Papadopoulos, V. (2015) Global knockout and steroidogenic cell-targeted deletion of the translocator protein (18-kDa) unveil its crucial role in viability and hormone-dependent steroid formation. Endocrine Society's 97th Annual Meeting and Expo, San Diego, U.S.A., 5-8 March 2015, Abstract THR-277
75. Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B. and Midzak, A. (2015) Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol. Cell Endocrinol. 408, 90-98